Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol

Frontiers in Endocrinology(2021)10.3389/fendo.2021.789957Source: DataRank Database

Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol is a research paper published in Frontiers in Endocrinology (2021). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.58)OA: goldTopics (65)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Thomas Coudrat ORCID,Aditya J. Desai ORCID,Maoqing Dong ORCID,Daniela G. Dengler ORCID,Sebastian G. B. Furness ORCID

Live enrichment

PubMed:34950108 PMC:PMC8689142 OpenAlex:https://openalex.org/W4200012740

NIDDK NIH HHS

Grant: R01 DK115402

National Institutes of Health

Grant: 5R01DK115402-03

Universal positive allosteric modulators of CCK1R without intrinsic agonist activity for the treatment of obesity

Australian Research Council (ARC)

Grant: FT180100543

ARC Future Fellowships - Grant ID: FT180100543

National Institutes of Health

FWCI

0.58

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://doi.org/10.3389/fendo.2021.789957

publisherhttps://doi.org/10.3389/fendo.2021.789957

publisherhttps://www.frontiersin.org/articles/10.3389/fendo.2021.789957/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34950108

repositoryhttps://doaj.org/article/895703c860ab400c964a97eea810e55b

Fields of Study

Neuropeptides and Animal PhysiologyReceptor Mechanisms and SignalingEstrogen and related hormone effects0301 basic medicine03 medical and health sciences0303 health sciencesAllosteric RegulationAnimalsCHO CellsChemokines, CCCholecystokininCholesterolCricetinaeCricetulusDose-Response Relationship, DrugDrug DiscoveryHumansHypercholesterolemiaMacaca fascicularisMiceRats

MeSH Terms

Allosteric RegulationAnimalsCholecystokininCholesterolCricetulusDose-Response Relationship, DrugCricetinaeHumansHypercholesterolemiaMacaca fascicularisCHO CellsChemokines, CCMiceRatsDrug Discovery

Keywords

Allosteric regulationAllosteric modulatorCholecystokininAgonistCholecystokinin receptorPharmacologyReceptorChemistryBiologyBiochemistryCholesterolObesityAllosteric modulationHypercholesterolemiaCHO CellsDiseases of the endocrine glands. Clinical endocrinologyMiceEndocrinologyCricetulusCricetinaeDrug DiscoveryAnimalsHumansDose-Response Relationship, DrugRC648-665Rats2712 Endocrinology, Diabetes and MetabolismMacaca fascicularisChemokines, CC

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being